DELESTROGEN

LOE Approaching

estradiol valerate

NDAINJECTIONINJECTABLE
Approved
Jul 1954
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6

Mechanism of Action

CLINICAL PHARMACOLOGY Endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Although circulating estrogens exist in a dynamic equilibrium of metabolic interconversions, estradiol is the principal…

Indications (1)

Clinical Trials (5)

NCT04901377N/ACompleted

A Study to Gather Information About User Satisfaction in Women in Russia Who Take Estradiol Valerate/Dienogest

Started Jun 2021
255 enrolled
Oral Contraception
NCT03901131N/ACompleted

PROMES: A Clinical Study in Which Researchers Want to Learn More About the Safety Profile of MESIGYNA (Norethisterone Enantate 50 mg and Estradiol Valerate 5 mg) Used as a Medication to Prevent Pregnancy for Adult Women in Reproductive Age in the Peruvian Population at the Outpatient Clinic.

Started Aug 2019
296 enrolled
Contraceptive
NCT03300518N/ACompleted

Effectiveness of Estradiol Valerate Pretreatment in Antagonist Protocol for Poor Ovarian Response Patient

Started Nov 2017
552 enrolled
Infertility
NCT01638910Phase 3Completed

Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects

Started Jun 2012
955 enrolled
Contraception
NCT01031355Phase 1Completed

Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium

Started Dec 2009
42 enrolled
ContraceptionOvulation Inhibition